Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial

被引:40
作者
Chambers, ST
Sanders, J
Patton, WN
Ganly, P
Birch, M
Crump, JA
Spearing, RL
机构
[1] Christchurch Hosp, Dept Infect Dis, Christchurch, New Zealand
[2] Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand
[3] Christchurch Hosp, Dept Microbiol, Christchurch, New Zealand
关键词
exit-site infection; tunnelled intravascular catheter; chlorhexidine; neutropenia; chemotherapy;
D O I
10.1016/j.jhin.2005.01.023
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Exit-site and tunnel infections of tunnelled central intravascular catheters are a frequent source of morbidity among neutropenic patients and may necessitate catheter removal. They require antimicrobial therapy that increases healthcare costs and is associated with adverse drug reactions. A prospective randomized clinical trial, was conducted among adult patients undergoing chemotherapy in a haematology unit. Tunnelled intravascular catheters were randomized to receive the control of a standard dressing regimen as recommended by the British Committee for Standards in Haematology, or to receive the intervention of a sustained-release chlorhexidine dressing. Follow-up data were available in 112 of 114 tunnelled intravascular catheters which were randomized. Exit-site or combined exit-site / tunnel infections occurred in 23 (43%) of 54 catheters in the control. group, and five (9%) of 58 catheters in the intervention group [odds ratio (OR) for intervention group compared with control group = 0.13, 95% confidence intervals (CI) 0.04-0.37, P < 0.001]. More tunnelled intravascular catheters were prematurely removed from the control group than the intervention group for documented infections [20/54 (37%) vs 6/58 (10%), OR = 0.20, 95% CI 0.53-0.07]. However, there was no difference in the numbers of tunnelled intravascular catheters removed for all proven and suspected intravascular catheter-related infections [21/54 (39%) vs 19/58 (33%)], or in the time to removal of catheters for any reason other than death or end of treatment for underlying disease. Thus chlorhexidine dressings reduced the incidence of exit-site / tunnel infections of indwelling tunnelled intravascular catheters without prolonging catheter survival in neutropenic patients, and could be considered as part of the routine management of indwelling tunnelled intravascular catheters among neutropenic patients. (c) 2005 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 24 条
  • [1] ALSIBAI MB, 1987, CANCER, V6, P1891
  • [2] BLACKLOCK HA, 1980, LANCET, V1, P993
  • [3] Association between intensity of chlorhexidine use and micro-organisms of reduced susceptibility in a hospital environment
    Block, C
    Furman, M
    [J]. JOURNAL OF HOSPITAL INFECTION, 2002, 51 (03) : 201 - 206
  • [4] Cavill I, 1997, BRIT J HAEMATOL, V98, P1041
  • [5] Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis
    Chaiyakunapruk, N
    Veenstra, DL
    Lipsky, BA
    Saint, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (11) : 792 - 801
  • [6] EXPERIENCE WITH THE GROSHONG LONG-TERM CENTRAL VENOUS CATHETER
    DELMORE, JE
    HORBELT, DV
    JACK, BL
    ROBERTS, DK
    [J]. GYNECOLOGIC ONCOLOGY, 1989, 34 (02) : 216 - 218
  • [7] Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya
    Gaillard, P
    Mwanyumba, F
    Verhofstede, C
    Claeys, P
    Chohan, V
    Goetghebeur, E
    Mandaliya, K
    Ndinya-Achola, J
    Temmerman, M
    [J]. AIDS, 2001, 15 (03) : 389 - 396
  • [8] A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates
    Garland, JS
    Alex, CP
    Mueller, CD
    Otten, D
    Shivpuri, C
    Harris, MC
    Naples, M
    Pellegrini, J
    Buck, RK
    McAuliffe, TL
    Goldmann, DA
    Maki, DG
    [J]. PEDIATRICS, 2001, 107 (06) : 1431 - 1437
  • [9] HOWELL PB, 1995, CANCER, V75, P1367, DOI 10.1002/1097-0142(19950315)75:6<1367::AID-CNCR2820750620>3.0.CO
  • [10] 2-Z